Evidence map›Paper›PMID 37664346›Full record

ArticleCureus2023

Socio-Demographics of Initial Substance Use Exposure and Its Relation to Progression: A Cross-Sectional Study in Saudi Arabia.

Alaa Nabil Mahsoon, Lina Almashat, Norah Alsubaui, Shahad Hindi, Shahad Alharbi, Sara Yaghmour, Loujain Sharif

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alaa Nabil MahsoonDepartment of Psychiatric and Mental Health Nursing, Faculty of Nursing, King Abdulaziz University, Jeddah, SAU.
Lina AlmashatFaculty of Nursing, King Abdulaziz University, Jeddah, SAU.
Norah AlsubauiFaculty of Nursing, King Abdulaziz University, Jeddah, SAU.
Shahad HindiFaculty of Nursing, King Abdulaziz University, Jeddah, SAU.
Shahad AlharbiFaculty of Nursing, King Abdulaziz University, Jeddah, SAU.
Sara YaghmourDepartment of Psychiatric and Mental Health Nursing, Faculty of Nursing, King Abdulaziz University, Jeddah, SAU.
Loujain SharifDepartment of Psychiatric and Mental Health Nursing, Faculty of Nursing, King Abdulaziz University, Jeddah, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEmpirical evidence on substance use in Saudi Arabia is lacking. This quantitative study is aimed at describing the socio-demographics of initial exposure to substance use and its relation to substance abuse progression.

methodA questionnaire about socio-demographics during initial exposure to substance use was completed by 379 participants.

resultsFor most participants, the commencement of substance abuse occurred at the age range of 19‒23 years, and while in high school, they first started taking drugs with school friends. The two psychoactive substances most commonly taken for the first time were hashish and alcohol. The two main reasons for first drug exposure were teenage curiosity and joy-seeking. The chi-square test revealed statistically significant differences between substance abuse progression by sex, current age, father's education level, parent's marital status, and one's company in substance use. Female participants were more likely to continue taking drugs.

conclusionYoung people must be educated about the risks and consequences of substance use from early adolescence.

Indexed as

initial exposuresaudi arabiasocio-demographicssubstance abusesubstance users

Identifiers

PMID37664346
PMCPMC10469902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.